Scarica l'app Stockscreener
5.21
2.36%
0.12
Dopo l'orario di chiusura:
5.25
0.04
+0.77%
Cingulate Inc Borsa (CING) Ultime notizie
Why Is CING Stock Jumping Over 4% In Overnight Trading? - Stocktwits
Cingulate (NASDAQ:CING) Upgraded by Wall Street Zen to "Sell" Rating - MarketBeat
Cingulate Stock Price Forecast. Should You Buy CING? - StockInvest.us
Cingulate (NASDAQ:CING) Posts Quarterly Earnings Results - MarketBeat
Form 8K Cingulate Inc For: 13 August - Investing.com Nigeria
Cingulate reports Q2 loss, plans FDA resubmission for ADHD drug By Investing.com - Investing.com Canada
Form 8K Cingulate Inc For: 13 August By Investing.com - Investing.com Canada
Cingulate reports Q2 loss, plans FDA resubmission for ADHD drug - Investing.com Nigeria
Cingulate Inc. Q2 2026: Revenue $0 Net loss $5.87M — 10-Q Summary - TradingView
Cingulate Reports $5.9 Million Second-Quarter Loss, $28.4 Million Cash - Quiver Quantitative
Cingulate Reports Q2 2026 Results: $28.4M Cash; Net Loss $5.9M for Quarter - TradingView
Cingulate Inc. Reports Second Quarter 2026 Financial Results and Provides Update on CTx-1301 CMC Progress Towards NDA Resubmission and Commercial Readiness - marketscreener.com
Cingulate Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Cingulate Inc. Warrants (CINGW) Rise 9.72% to $0.01 as Support and Resistance AlignSmall Cap Breakouts - dars.gov.et
Cingulate publishes pharmacokinetic study on ADHD drug candidate - Investing.com
Cingulate publishes pharmacokinetic study on ADHD drug candidate By Investing.com - Investing.com Canada
Cingulate Publishes Peer-Reviewed Data Demonstrating CTx-1301’s Differentiated Pharmacokinetic Profile - GlobeNewswire
CING Q2'26 Earnings: revenue estimate is 0 USD - TradingView
Cingulate (CING) Expected to Announce Earnings on Tuesday - MarketBeat
Cingulate Inc. Revenue Breakdown – BOATS:CINGW - TradingView
Cingulate Inc (CING) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Cingulate Inc (CING) Stock News Today - TradingKey
Cingulate Inc. Warrants (CINGW) Fall 7.14% to $0.01 as Price Compresses at Key SupportKAMA Signal - dars.gov.et
Cingulate publishes phase 3 ADHD drug trial results in journal By Investing.com - Investing.com Nigeria
Cingulate Inc. Warrants (CINGW) Hold at $0.01 After 8.33% Gain as Speculative Interest PersistsLiquidity Order Flow - dars.gov.et
Cingulate Inc. Warrants (CINGW) Edge Lower as Trading Remains Tight Near $0.02IV Rank - dars.gov.et
Cingulate Inc (CING) Cash Flow - TradingKey
Cingulate Inc (CING) Income Statement - TradingKey
Cingulate Inc (CING) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Cingulate Inc (CING) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Cingulate Inc (CING) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
CING|Cingulate Inc|Price:4.595|Chg%:-0.045 - TradingKey
Cingulate Inc (CING) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Cingulate Inc (CING) Balance Sheet - TradingKey
Cingulate Inc (CING) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Cingulate Inc (CING) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Cingulate Inc. Revenue Breakdown – NASDAQ:CINGW - TradingView
CING|Cingulate Inc|Price:4.340|Chg%:-0.180 - TradingKey
CING|Cingulate Inc|Price:4.640|Chg%:-0.200 - TradingKey
CING|Cingulate Inc|Price:4.500|Chg%:-0.140 - TradingKey
Enterprise value to EBIT forward of Cingulate Inc. – NASDAQ:CINGW - TradingView
Cingulate (NASDAQ:CING) Stock Price Down 4.1%What's Next? - MarketBeat
Cingulate (NASDAQ: CING) to end Chief Legal Officer position, Patel departing - Stock Titan
Nilay Patel to Leave Cingulate as Chief Legal Officer Position Eliminated - TradingView
Cingulate (CING) Registration filing Summary - Quartr
Form 4 Cingulate Inc For: 21 July By Investing.com - Investing.com South Africa
CING Q1 2026 Earnings: Wider-Than-Expected Loss Masks Operational Progress, Shares RiseEarnings Call Q&A - po-news-eg.net
CING Q1 2026 Earnings: Wider-than-Expected Loss Reported; Stock Rises Despite No RevenueEarnings Trend Analysis - dars.gov.et
Cingulate enhances equity plan and updates board leadership - The Globe and Mail
Cingulate Inc. Files 8-K with SEC: Key Corporate Details, Emerging Growth Status, and Nasdaq Listing Information - Minichart
Cingulate Inc. Announces Board and Committee Changes, Effective July 9, 2026 - marketscreener.com
Cingulate (Nasdaq: CING) adds 625K incentive shares, CEO named chair - Stock Titan
1.80%
1.77%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):